Pilot RCT of Self-stigma Treatment for First Episode Psychosis
Launched by JOHN JAY COLLEGE OF CRIMINAL JUSTICE, CITY UNIVERSITY OF NEW YORK · May 13, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new approach to help young people aged 15 to 24 who are experiencing their first episode of psychosis. Psychosis can cause symptoms like seeing or hearing things that aren't there, and it can be really challenging for those affected. The study aims to adapt an existing treatment called NECT to better meet the needs of young individuals. The goal is to help them feel better about themselves and their illness, which may encourage them to engage more with their treatment. Participants will receive this modified treatment alongside regular care services, and researchers want to see how effective it is compared to just the regular care.
To be eligible for the study, participants need to be between 15 and 24 years old and have experienced psychotic symptoms in the last five years without any major substance use or mood disorders. They should also have some level of self-stigma, meaning they might feel negatively about themselves because of their mental health. If someone decides to join the study, they can expect to participate in group sessions and assessments, and they will be part of a small group of around 40 participants. This is a great opportunity to contribute to research that could help improve treatment for young people dealing with similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Meets criteria for FEP youth based on the following definition: age 15-24, onset of psychotic symptoms within the last 5 years, and an absence of a primary substance use or mood disorder that could be causing the psychotic symptoms (confirmed by program eligibility);
- • 2. Meets criteria for moderate (defined as a mean score of 1-1.5 on the 0-3 scale of the Internalized Stigma of Mental lllness Scale \[ISMI\]) or elevated (defined as a mean score of 1.5-3 on the 0-3 scale of the ISMI) self-stigma;
- • 3. Speaks English well enough to complete assessments and participate in groups;
- • 4. Is able to provide informed consent to participate.
- Exclusion Criteria:
- • Does not meet any of the above inclusion criteria.
About John Jay College Of Criminal Justice, City University Of New York
John Jay College of Criminal Justice, part of the City University of New York, is a leading institution dedicated to the study of criminal justice, forensic psychology, and public safety. With a strong emphasis on research and evidence-based practices, the college actively engages in clinical trials that aim to enhance understanding of criminal behavior, improve interventions, and promote community safety. By fostering interdisciplinary collaboration among experts in criminology, psychology, and law, John Jay College strives to contribute valuable insights to the fields of justice and public health, ensuring that findings are effectively translated into practical applications for policymakers and practitioners.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Indianapolis, Indiana, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials